Search Within

Sham Mailankody

Formats
  1. Meeting Abstract (169)
  2. Journal Article (98)
  3. Research Letter (12)
  4. Review (10)
  5. Correspondence (5)
  6. Editorial (2)
  7. Guidelines (1)
Groups
  1. Center for Hematologic Malignancies (297)
  2. Department of Medicine (297)
  3. Hematologic Malignancies, Division of (297)
  4. Myeloma (297)
  5. Survivorship Research (216)
  6. Hematologic Malignancies Research (212)

More Groups

People
  1. Neha Korde (191)
  2. Alexander Lesokhin (170)
  3. Hani Hassoun (163)
  4. Sergio Giralt (161)
  5. Malin Hultcrantz (158)
  6. Heather Landau (147)

More People

Years
  1. 2025 (13)
  2. 2024 (46)
  3. 2023 (49)
  4. 2022 (44)
  5. 2021 (22)
  6. 2020 (22)

More Years

Publications
  1. Blood (96)
  2. Clinical Lymphoma, Myeloma and Leukemia (46)
  3. Journal of Clinical Oncology (23)
  4. Blood Cancer Journal (12)
  5. JAMA Oncology (12)
  6. Leukemia and Lymphoma (10)

More Publications

Publishers
  1. American Society of Hematology (107)
  2. Elsevier Inc. (71)
  3. Nature Publishing Group (26)
  4. American Society of Clinical Oncology (24)
  5. American Medical Association (18)
  6. Taylor & Francis Group (10)

More Publishers

Results (297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma
    Journal Article

    Mailankody, S.; Kazandjian, D.; Korde, N.; Roschewski, M.; Manasanch, E.; Bhutani, M.; Tageja, N.; Kwok, M.; Zhang, Y.; Zingone, A.; more...
    Blood Advances (2017)

    Fulltext@MSK | Save
  • Galinpepimut-S, a WT1-targeting immuno-oncology treatment, induces specific, robust and durable immune responses (IRs) in patients (Pts) with high-risk (HR) multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Korde, N.; Mailankody, S.; Heather, L.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Sarlis, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2017)

    Fulltext@MSK | Save
  • Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving lenalidomide maintenance
    Journal Article

    Hassoun, H.; Roshal, M.; Sabari, J.; Nguyen, J.; Gao, Q.; Devlin, S. M.; Landau, H.; Lendvai, N.; Chung, D. J.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM)
    Meeting Abstract

    Koehne, G.; Devlin, S.; Chung, D.; Landau, H.; Korde, N.; Mailankody, S.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Overall survival in cancer drug trials as a new surrogate end point for overall survival in the real world
    Journal Article

    Mailankody, S.; Prasad, V.
    JAMA Oncology (2017)

    Fulltext@MSK | Save
  • Pharmaceutical marketing for rare diseases: Regulating drug company promotion in an era of unprecedented advertisement
    Journal Article

    Mailankody, S.; Prasad, V.
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease
    Journal Article

    Hofmann, J. N.; Mailankody, S.; Korde, N.; Wang, Y.; Tageja, N.; Costello, R.; Zingone, A.; Hultcrantz, M.; Pollak, M. N.; Purdue, M. P.; more...
    Obesity (2017)

    Fulltext@MSK | Save
  • Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms
    Journal Article

    Sissung, T. M.; Peer, C. J.; Korde, N.; Mailankody, S.; Kazandjian, D.; Venzon, D. J.; Landgren, O.; Figg, W. D.
    Cancer Chemotherapy and Pharmacology (2017)

    Fulltext@MSK | Save
  • The high price of anticancer drugs: Origins, implications, barriers, solutions
    Journal Article

    Prasad, V.; De Jesús, K.; Mailankody, S.
    Nature Reviews Clinical Oncology (2017)

    Fulltext@MSK | Save
  • The rising price of cancer drugs - A new old problem?
    Journal Article

    Prasad, V.; Wang, R.; Afifi, S. H.; Mailankody, S.
    JAMA Oncology (2017)

    Fulltext@MSK | Save